Brief: Kymera Therapeutics Announces Sanofi Irak4 Collaboration Update
25/06/2025 12:06
June 25 (Reuters) - Kymera Therapeutics Inc KYMR.O: KYMERA THERAPEUTICS ANNOUNCES SANOFI IRAK4 COLLABORATION UPDATE KYMERA THERAPEUTICS INC - SANOFI TO ADVANCE KYMERA'S KT-485 INTO CLINICAL TESTING KYMERA THERAPEUTICS INC - ELIGIBLE FOR UP TO $975 MILLION IN MILESTONES KYMERA THERAPEUTICS INC - KT-485 SHOWS INCREASED SELECTIVITY AND POTENCY IN PRECLINICAL TESTING Source text: ID:nGNXc1jhqZ Further company coverage: KYMR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer